Comparison of direct medical costs between automated and continuous ambulatory peritoneal dialysis

Peritoneal Dialysis International

Volumn 33, Issue 6, 2013, Pages 679-686

  Cortés Sanabria, Laura ^a   Rodríguez Arreola, Brenda E ^b   Ortiz Juárez, Victor R ^b   Soto Molina, Herman ^c   Pazarín Villaseñor, Leonardo ^a   Martínez Ramírez, Héctor R ^a   Cueto Manzano, Alfonso M ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Automated peritoneal dialysis; Continuous ambulatory peritoneal dialysis; Direct costs

Indexed keywords

ERYTHROPOIETIN; IRON;

ADULT; ARTICLE; AUTOMATED AMBULATORY PERITONEAL DIALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; COST BENEFIT ANALYSIS; DRUG COST; EMERGENCY WARD; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL COST; HOSPITALIZATION COST; HUMAN; KIDNEY FAILURE; KIDNEY SURGERY; LABORATORY TEST; MALE; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS CATHETER; PERITONITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AUTOMATED PERITONEAL DIALYSIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIRECT COSTS;

ADULT; AGED; FEMALE; HUMANS; LINEAR MODELS; MALE; MEXICO; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; RETROSPECTIVE STUDIES;

EID: 84889564486     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2011.00274     Document Type: Article

References (29)

1. United States, Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, US Renal Data System (USRDS). Home> Archive> 2008 Annual Data Report (Web page). Bethesda, MD: USRDS; 2008. [Available at: http://www.usrds.org/atlas08.aspx; accessed 2August 2010]
2. Instituto Nacional de Geografía y Estadística (INEGI). Summary Table: Social Indicators [Web page, Spanish]. Aguascalientes, Mexico: INEGI; 2013. [Available at: http://www.inegi.org.mx/Sistemas/temasV2/Default.aspx?s=est&c=21702; accessed 13March 2013]
3. Cueto-Manzano AM, Rojas-Campos E. Status of renal replacement therapy and peritoneal dialysis in Mexico. Perit Dial Int 2007; 27:142-8.
4. Garcia-Garcia G, Monteon-Ramos JF, Garcia-Bejarano H, Gomez-Navarro B, Reyes IH, Lomeli AM, et al. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL). Kidney Int Suppl 2005; (97):S58-61.
5. Instituto Mexicano del Seguro Social (IMSS). Chapter II: Economic Environment, Demographic, Epidemiological and Social [Spanish]. Juárez, Mexico: IMSS; 2005. [Available online at: http://www.imss.gob.mx/instituto/informes/Documents/II.%20Entorno%20Económico,%20Demográfico,%20Epidemiológico%20y%20Social.pdf; accessed 13March 2013]
6. Rabindranath KS, Adams J, Ali TZ, Daly C, Vale L, Macleod AM. Automated vs continuous ambulatory peritoneal dialysis: a systematic review of randomized controlled trials. Nephrol Dial Transplant 2007; 22:2991-8.
7. Badve SV, Hawley CM, McDonald SP, Mudge DW, Rosman JB, Brown FG, et al. Automated and continuous ambulatory peritoneal dialysis have similar outcomes. Kidney Int 2008; 73:480-8.
8. Mujais S, Story K. Peritoneal dialysis in the US: evaluation of outcomes in contemporary cohorts. Kidney Int Suppl 2006; (103):S21-6.
9. Sanchez AR, Madonia C, Rascon-Pacheco RA. Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center. Kidney Int Suppl 2008; (108):S76-80.
10. Neil N, Walker DR, Sesso R, Blackburn JC, Tschosik EA, Sciaraffia V, et al. Gaining efficiencies: resources and demand for dialysis around the globe. Value Health 2009; 12:73-9.
11. Pecoits-Filho R, Campos C, Cerdas-Calderon M, Fortes P, Jarpa C, Just P, et al. Policies and health care financing issues for dialysis in Latin America: extracts from the roundtable discussion on the economics of dialysis and chronic kidney disease. Perit Dial Int 2009; 29(Suppl 2):S222-6.
12. Arredondo A, Rangel R, De Icaza E. Costs of interventions for patients with chronic renal disease (Spanish). Rev Saude Publica 1998; 32:255-61.
13. Otero CF, Maimone MAS, Rodriguez AR, Martínez CA, Barzalobre AS, Chávez CJ, et al. Cost effectiveness analysis for patients with CKD on dialysis (Spanish). Nefrol Mex 2002; 23: 147-56.
14. Mexico, Department of the Interior (SEGOB). Diario Oficial de la Federación, Órgano del Gobierno Constitucional de los Estados Unidos Mexicanos. Federal District, Mexico: SEGOB; 2008: DCLIV 20:76-7.
15. Mexico, Department of the Interior (SEGOB). Diario Oficial de la Federación, Órgano del Gobierno Constitucional de los Estados Unidos Mexicanos. Federal District, Mexico: SEGOB; 2010: DCLXXX 11:85-8.
16. Velasco Rodríguez VM, Martínez Ordaz VA, Roiz Hernández J, Huazano Garcia F, Nieves Renteria A, eds. Sampling and Sample Size. A Practical Guide for Health Staff Conducting Research [Spanish]. Torreón, Mexico: e-libro. net; 2002.
17. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med 2006; 354:997-9.
18. Schieppati A, Remuzzi G. Chronic renal disease as a public health problem: epidemiology, social, and economic implications. Kidney Int Suppl 2005; (98):S7-10.
19. Hamer RA, El Nahas AM. The burden of chronic kidney disease. BMJ 2006; 332:563-4.
20. World Health Organization (WHO). Tough Choices: Investing in Health for Development. Experiences from National Follow-Up to the Commission on Macroeconomics and Health. Geneva, Switzerland: WHO; 2006. [Available online at: http://www.who.int/macrohealth/documents/report_and_cover.pdf; accessed 19August 2010]
21. Peeters P, Rublee D, Just PM, Joseph A. Analysis and interpretation of cost data in dialysis: review of western European literature. Health Policy 2000; 54:209-27.
22. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999; 14(Suppl 6):31-41.
23. Baboolal K, McEwan P, Sondhi S, Spiewanowski P, Wechowski J, Wilson K. The cost of renal dialysis in a UK setting-a multicentre study. Nephrol Dial Transplant 2008; 23:1982-9.
24. Just PM, Riella MC, Tschosik EA, Noe LL, Bhattacharyya SK, de Charro F. Economic evaluations of dialysis treatment modalities. Health Policy 2008; 86:163-80.
25. Horl WH, de Alvaro F, Williams PF. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: access to ESRD treatments. Nephrol Dial Transplant 1999; 14(Suppl 6):10-15.
26. Pacheco A, Saffie A, Torres R, Tortella C, Llanos C, Vargas D, et al. Cost/utility study of peritoneal dialysis and hemodialysis in Chile. Perit Dial Int 2007; 27:359-63.
27. Berger A, Edelsberg J, Inglese GW, Bhattacharyya SK, Oster G. Cost comparison of peritoneal dialysis versus hemodialysis in end stage renal disease. Am J Manag Care 2009; 15:509-18.
28. Grun RP, Constantinovici N, Normand C, Lamping DL on behalf of the North Thames Dialysis Study Group. Cost of dialysis for elderly people in the UK. Nephrol Dial Transplant 2003; 18:2122-7.
29. Piraino B, Bernardini J, Johnston J. Cost analysis of peritoneal catheter infections. Perit Dial Int 1990; 10:241-2.